49 results
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:36pm
treatments and the potential of their own lives while simultaneously lowering healthcare costs. To accomplish this, Comera is developing an internal … simultaneously lowering healthcare costs and increasing patient compliance.
The SQore™ platform, which is the foundation of our work, is supported
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:35pm
treatments and the potential of their own lives while simultaneously lowering healthcare costs. To accomplish this, Comera is developing an internal … simultaneously lowering healthcare costs and increasing patient compliance.
The SQore™ platform, which is the foundation of our work, is supported
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:33pm
treatments and the potential of their own lives while simultaneously lowering healthcare costs. To accomplish this, Comera is developing an internal … simultaneously lowering healthcare costs and increasing patient compliance.
The SQore™ platform, which is the foundation of our work, is supported
8-K
EX-99.1
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights
4:31pm
our value proposition, we remain focused on our mission to improve patient quality of life and reduce healthcare costs by leveraging our SQore™ platform
424B3
1v9av4adaipnul5d72
13 Sep 23
Prospectus supplement
4:30pm
S-3
s2r1xgs
29 Aug 23
Shelf registration
4:31pm
DEF 14A
bhnjc6di
11 Aug 23
Definitive proxy
4:15pm
8-K
EX-99.1
56fprectz1gl79x4
10 Aug 23
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights
5:30pm
424B3
wd8dd9yf zo85
10 Aug 23
Prospectus supplement
4:37pm
424B3
bp7ytty5
10 Aug 23
Prospectus supplement
4:32pm
424B3
pc1lps6eq7
10 Aug 23
Prospectus supplement
4:32pm
PRE 14A
utg7b0i kxl
1 Aug 23
Preliminary proxy
5:08pm
424B3
0y5b9fp18jzssp8v gdw
16 May 23
Prospectus supplement
4:33pm
424B3
gg0cpsvcg
16 May 23
Prospectus supplement
4:31pm
424B3
8uuyt
16 May 23
Prospectus supplement
4:31pm
8-K
EX-99.1
5byxyi
12 May 23
Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights
4:31pm
424B3
86aunxh7zd0j 54f
31 Mar 23
Prospectus supplement
4:34pm